FDA Headquarters Consolidation Initiative - Workplace Enhancement and Management Services
ID: OC-2025-122493_FDA_Headquarters_WEMS-8(a)Sole_Source_AwardType: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFFOOD AND DRUG ADMINISTRATIONFDA OFFICE OF ACQ GRANT SVCSBeltsville, MD, 20705, USA

NAICS

Administrative Management and General Management Consulting Services (541611)

PSC

SUPPORT- PROFESSIONAL: PROGRAM MANAGEMENT/SUPPORT (R408)

Set Aside

8(a) Sole Source (FAR 19.8) (8AN)

Original Source

https://sam.gov/opp/a1db9e61801a41c9a489bdd438afce87/view
Timeline
    Description

    The Department of Health and Human Services, through the Food and Drug Administration (FDA), intends to award an 8(a) sole source contract for Workplace Enhancement and Management Services as part of the FDA Headquarters Consolidation Initiative. The primary objective of this procurement is to enhance space efficiency at the FDA Headquarters in Silver Spring, Maryland, necessitating comprehensive space planning, project management for office renovations, and furniture coordination. This initiative is crucial for optimizing the operational environment to support the FDA's mission of promoting public health, with a total estimated contract value of $4,269,388.87 for a base year and two optional years, starting January 1, 2025. Interested parties may submit qualifications and capabilities by 10:00 AM ET on November 12, 2024, to Andrea Howard at andrea.howard1@fda.hhs.gov or Sandra Bellinger at sandra.bellinger@fda.hhs.gov.

    Point(s) of Contact
    Andrea Howard
    (240) 402-7197
    andrea.howard1@fda.hhs.gov
    Sandra Bellinger
    sandra.bellinger@fda.hhs.gov
    Files
    Title
    Posted
    PWS_30 Oct 2024_DRAFT.docx
    The Performance Work Statement (PWS) outlines the contract requirements for Workplace Enhancement and Management Services at the FDA Headquarters. The objective is to improve space efficiency due to increasing personnel needs, which includes comprehensive space planning, project management for office renovations, and furniture coordination. The contractor must provide five full-time key personnel with specific expertise in architecture, project management, and furniture management, adhering to strict qualifications and responsibilities. The contract encompasses various task areas, including space allocation planning, project development and management, furniture management, and move management. Key personnel are responsible for documentation, project planning, and collaboration with the FDA's Office of Facilities, Engineering and Mission Support (OFEMS) and other stakeholders. The contract is expected to start on January 1, 2025, for a base year with two optional years. Crucially, the government will provide necessary facilities and equipment, while contractors are responsible for maintaining a qualified workforce, implementing quality control measures, and reporting project progress regularly. This initiative underscores the FDA's commitment to optimizing its operational environment in support of its mission to promote public health.
    Similar Opportunities
    FY25 Docker Enterprise Edition Licenses
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking proposals for the procurement of Docker Enterprise Edition licenses to support the development of its Containers as a Service (CaaS) platform. The objective of this contract is to enhance the FDA's IT infrastructure by utilizing Docker EE’s container technology, which is essential for improving operational efficiency and reducing costs compared to traditional virtual machines. This procurement is significant as it enables the FDA to deploy applications in various environments while ensuring compliance with federal security mandates. Interested small businesses must submit their quotes by January 2, 2025, and can direct inquiries to Terina Hicks at terina.hicks@fda.hhs.gov or Roosevelt Walker at roosevelt.walker@fda.hhs.gov.
    Bruker Maldi TOF Maintenance
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is seeking proposals for a full-service maintenance agreement for its Bruker MALDI TOF system, with a contract start date of January 16, 2025, and four optional one-year extensions. The contractor will be responsible for comprehensive maintenance services, including all repairs, annual preventative maintenance, and ensuring compliance with regulatory standards, with a focus on supporting the FDA's mission to monitor antimicrobial resistance in foodborne and zoonotic pathogens. Interested small businesses must submit their quotes by 11:59 PM EST on January 3, 2025, and can direct inquiries to James O’Keefe at 301-796-7371 or via email at James.OKeefeIII@fda.hhs.gov.
    FDA Regulated Products Sampling Services
    Active
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is seeking qualified vendors to provide Sampling Services for FDA-regulated products through a Sources Sought Notice (Ref No. 75F40125R00032). The primary objective of this procurement is to identify capable businesses that can collect physical samples of food, drugs, medical devices, and other products for laboratory analysis, ensuring safety and verifying labeling accuracy. This initiative is crucial for the FDA's regulatory oversight, as it supports the monitoring of product safety and quality, which may include both domestic and imported goods. Interested parties must submit their responses by January 9, 2025, and can contact Amanda Lusk at Amanda.Lusk@fda.hhs.gov or Nicholas Bisher at Nicholas.Bisher@fda.hhs.gov for further information.
    FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is soliciting proposals through the FY25 Broad Agency Announcement (BAA) aimed at advancing regulatory science and innovation. This opportunity invites organizations, particularly small businesses, to submit research and development proposals that address critical areas such as alternative drug development methods, advanced manufacturing technologies, and predictive toxicology, with a strong emphasis on including diverse populations in research. Proposals must be submitted by February 24, 2025, and will undergo a two-tier evaluation process, with the potential for multiple contracts awarded based on proposal quality and funding availability. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    PRIMO Software Licensing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide PRIMO Software Licensing and Maintenance Support Services. The procurement involves supplying 21 PRIMO software licenses for a base year, with two additional option years, to ensure the continuous operation of the FDA's CFSAN CAEMS system. This software is crucial for pharmacovigilance and regulatory compliance, enhancing the FDA's capabilities in monitoring food safety. Interested parties must submit their quotes by August 26, 2024, and are encouraged to contact Roosevelt Walker at roosevelt.walker@fda.hhs.gov for further details. The contract will be awarded as a firm-fixed-price purchase order, emphasizing compliance with federal acquisition regulations and accessibility standards.
    Solicitation: Tobacco Retailer Inspections - 75F40125R00018
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is soliciting proposals for an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to conduct tobacco retailer inspections across multiple regions in the United States. The primary objective of this procurement is to ensure compliance with federal laws regarding the sale and advertising of tobacco products, particularly focusing on preventing youth access to these products. This initiative is critical for enhancing the FDA's enforcement capabilities and protecting public health by reducing tobacco use among minors. Interested contractors should contact Janice Heard at janice.heard@fda.hhs.gov or Brandon Rafus at brandon.rafus@fda.hhs.gov for further details, with the contract period spanning five years and specific funding amounts to be determined for each region.
    QIACube Maintenance Agreement
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking proposals for a maintenance agreement for its QIACube system, essential for the Atlanta Human and Animal Food Laboratory's molecular biology operations. The procurement requires a comprehensive service agreement that includes repair, labor, travel, and a loaner instrument, ensuring compliance with ISO accreditation standards and continuity in critical DNA and RNA extraction processes. The contract will commence on February 1, 2025, and run for one year, with options for four additional years, and proposals are due by 11:59 PM EST on January 3, 2025. Interested vendors can contact James O’Keefe at 301-796-7371 or via email at James.OKeefeIII@fda.hhs.gov for further information.
    Notice of Intent to Sole Source—AE Management and Inspection (M&I) Services for the 3rd & 4th Floor Laboratories
    Active
    General Services Administration
    The General Services Administration (GSA) intends to award a sole-source contract for Architect/Engineer Management and Inspection (M&I) Services for the renovation of the 3rd and 4th Floor Laboratories at the Harvey W. Wiley Federal Building in College Park, Maryland. The selected firm, N.K. Bhandari, Architecture & Engineering, P.C., will provide essential services including contract administration and quality assurance inspection, leveraging their original design knowledge to ensure project objectives are met. This procurement is critical for maintaining compliance with construction standards and ensuring a safe work environment during renovations, with an estimated contract award date set for April 2025. Interested parties may submit capability statements by January 2, 2025, to the designated contacts, Tracy Parker and LaShawn Lee, via email.
    Food Applications Regulatory Management (FARM) System
    Active
    Health And Human Services, Department Of
    The U.S. Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking information from small businesses capable of providing information technology support services for the Food Applications Regulatory Management (FARM) System as part of its Human Foods Program (HFP). The objective of this Request for Information (RFI) is to identify potential vendors who can enhance ongoing operations, maintenance, and development of various IT systems, ensuring improved workflows, data quality, and comprehensive management of IT operations related to food safety and nutrition. Interested parties are encouraged to submit detailed capability statements that address their relevant experience and solutions by January 13, 2025, and must be appropriately registered to qualify for consideration. For further inquiries, vendors can contact Brian Wodzisz at Brian.Wodzisz@fda.hhs.gov or by phone at 301-796-7376.
    Access to Outpatient Longitudinal Drug Utilization Data
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide access to outpatient longitudinal drug utilization data through a Sources Sought notice. The primary objective is to acquire existing, HIPAA-compliant data resources that will enhance drug safety evaluations, support post-market surveillance, and inform regulatory decisions, rather than developing new databases. This initiative is crucial for monitoring medication utilization trends, particularly in areas such as opioid surveillance, and aims to improve public health outcomes through rigorous analyses of drug safety data. Interested firms must submit their responses by January 23, 2025, including their business size status and DUNS number, and can direct inquiries to Telisha Wilson at telisha.wilson@fda.hhs.gov.